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Purpose: To evaluate asymptomatic cardiac disease in patients 
with ocular pseudoexfoliation.
Patients and Method: Forty-two patients with ocular 
pseudoexfoliation (with or without glaucoma) and 40 patients 
without pseudoexfoliation, who had no positive signs or symptoms 
of cardiac diseases, were enrolled in this study. For each participant 
a standard treadmill exercise test, as a noninvasive and reliable 
method for detecting ischemic heart disease, was performed under 
supervision of a cardiologist. The prevalence of ischemic heart 
disease was compared in the case and control groups.
Results: The mean age of participants was 68.38 ± 8.10 years in 
the case and 62.45 ± 8.40 years in the control group. There was 
no statistically significant difference between the two groups in 
terms of diabetes mellitus, hyperlipidemia, smoking, and family 
history of ischemic heart disease. Twenty patients (47.6  %) 
with pseudoexfoliation and 9 participants (22.5 %) without 
pseudoexfoliation had hypertension (P = 0.02). There were 10 
(23.8  %) positive exercise tests in the pseudoexfoliation group 
and 8 (20 %) positive exercise tests in participants without 
pseudoexfoliation (P = 0.78).
Conclusion: Based on our findings ocular pseudoexfoliation was 
not associated with increased risk of asymptomatic ischemic heart 
disease as evaluated by the treadmill exercise test.
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Introduction
Pseudoexfoliation (PEX) syndrome, first 
described by Lindberg, is an age related 
fibrillopathy, which is caused by deposition of 
fibrillar material in the anterior segment of the 
eye, specially the anterior lens capsule 1. PEX 
is reported to be the most common identifiable 
cause of open angle glaucoma 2. However, 
not all patients with PEX develop glaucoma. 
The proportion of people worldwide affected 
by this syndrome ranges from 0.5 % in those 
younger than 60 years to 15 % in people 
aged 60 years and older 3,4. In addition to 
ocular involvement, pseudoexfoliative 
fibrils have been found in many organs such 
as heart, lung, liver, kidney, and meninges 
by electron microscopy; therefore PEX 
syndrome has been known as a generalized 
disorder involving various visceral organs 5,6. 
Elevated serum antiphospholipid antibodies, 
a known risk factor for cardiovascular and 
cerebrovascular disease, are also more 
common in patients with PEX 7. Although 
deposition of pseudoexfoliative fibers in the 
cardiovascular system has been documented, 
the studies regarding the relation between 
PEX and coronary artery disease (CAD) 
have produced conflicting results with some 
studies proposing that PEX might be related 
to cardiovascular mortality 8-11, while others 
indicating the opposite 12-14. The aim of the 
present study was to evaluate the relationship 
between asymptomatic CAD discovered in 
treadmill exercise test and PEX.
Patients and Methods
In this prospective case control study a total of 
42 patients with ocular PEX with or without 
glaucoma and 40 participants without PEX 
were enrolled. Signed informed consent was 
obtained from all patients, and the ethical 
committee of the Iran University of Medical 
Sciences, Tehran, Iran, approved the study. 
PEX was diagnosed based on observing the 
deposition of pseudoexfoliative material 
in pupillary margin, lens capsule, or angle 
in at least one eye before or after pupillary 
dilation under slit lamp examination and 
gonioscopy. None of study participants 
had a positive history of cardiac diseases or 
was under treatment for cardiac diseases. A 
comprehensive eye examination including 
IOP measurement by calibrated Goldmann 
applanation tonometer, Snellen chart best 
corrected visual acuity (BCVA), Sussman 
gonioscopy, slit lamp examination, and hand 
held + 78 lens fundoscopy was performed in 
all participants. Risk factors of ischemic heart 
disease including age, sex, diabetes mellitus, 
hypertension, hyperlipidemia, smoking, and 
family history of ischemic heart disease (first 
degree family) was recorded based on the 
interviews with participants and from their 
available medical records. Inclusion criteria 
for the case group included the presence of 
PEX disease and age between 50 and 85 years. 
The exclusion criteria included any other kinds 
of glaucoma, history of chest pain or dyspnea, 
CCU admission, medical treatment for cardiac 
disease, or disability to perform exercise tests 
such as in patients with osteoarthritis. The 
inclusion and exclusion criteria for the control 
group were similar to the case group except for 
the presence of PEX. 
For detection of asymptomatic ischemic heart 
disease, a treadmill exercise test, which is a 
noninvasive test with sensitivity of about 68 % 
to 78 % 15-17, was performed for all participants 
under supervision of a cardiologist. The test 
period was determined depending on the 
age of the participant and the test was ended 
in the case of cardiac symptoms appearing. 
Detection of ST depression during the test 
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was reported as a positive exercise test. A test 
was considered negative only when a subject 
had achieved 85 % of the maximum heart 
rate predicted and did not have positive ST-T 
changes. 
A sample size of 40 participants in each group 
was calculated to detect a difference of 20 % in 
ST-T changes with a confidence of 95 % and 
statistical power of 80 % 18. Data analysis was 
performed using SPSS version 20 (Armonk, 
NY: IBM Corp.), and chi-square and Student’s 
t-test were used for comparing proportions 
and means between the two groups. Logistic 
regression backward method was used for 
multivariate analysis.  P values less than 0.05 
were considered statistically significant.
Results
The mean age of patients was 68.38 ± 8.10 
years (range 50 to 82 years) in the PEX 
group and 62.45 ± 8.40 years (range 50 
to 85 years) in participants without PEX 
(P = 0.07). Nine patients in the case and 7 
participants in the control group had diabetes 
(P = 0.54). There were twenty patients with 
PEX and 9 participants without PEX showing 
hypertension (P = 0.02). Thirteen patients in 
the case group and 6 participants in the control 
group had hyperlipidemia (P = 0.11). None 
of the patients with PEX and 4 participants 
without PEX had a family history of ischemic 
heart disease (P = 0.91). Four patients in the 
control group and 3 participants in the case 
group were smokers (P = 0.48). There were 
10 (23.8 %) positive exercise tests in the PEX 
group and 8 (20 %) positive exercise tests 
among participants without PEX (P = 0.78).
In a logistic regression analysis using the 
treadmill test as the outcome and PEX and 
other risk factors as the predictors, only sex 
and hypertension showed correlation with 
treadmill results.
Discussion
PEX is a systemic disorder with a particularly 
high prevalence in Scandinavian countries 19. 
The disease is characterized by deposition of 
extracellular material, which in most cases is 
easily detectable in the anterior segment of the 
eye and might also be found in other tissues, 
such as blood vessels, skin, gallbladder, 
kidneys, lungs, cerebral meninges, and 
heart 5,6,20,21. These findings have led to the 
hypothesis that PEX is more likely a systemic 
disorder with multiple clinical manifestations. 
In our study, we found that although patients 
with ocular PEX had a higher chance of 
having hypertension, there was no statistically 
significant difference in standard treadmill 
exercise test results as a sign of asymptomatic 
ischemic heart disease, between patients 
with ocular PEX and participants without 
PEX. In line with our finding Shrum et 
al., 12 in their study including 472 patients 
who were diagnosed with PEX syndrome 
or pseudoexfoliative glaucoma at the Mayo 
Clinic, from 1976 to 1995, found no association 
between ocular PEX and cardiovascular or 
cerebrovascular mortality. Also Brajkovic et 
al., 14 investigated the relationship between 
PEX and hypertension, CAD, arrhythmia, 
diabetes, and cerebrovascular accidents, and 
only arrhythmia was found to be higher in PEX 
patients. No relationship was found between 
PEX and mortality or other risk factors 14.   
Contrary to our results several previous 
studies have reported an association between 
ocular PEX and CAD 8,10,22,23, asymptomatic 
myocardial diastolic dysfunction 24, peripheral 
vascular disease 25, abdominal aortic aneurysm 
20, heart failure 26, and subclinical myocardial 
ischemia 27. 
Wang et al., 28 reported that PEX is associated 
with an increased risk of vascular disease, 
and Ciçek Yılmaz et al.,29 study showed that 
Cardiac disease in pseudoexfoliation Nilforushan et al.
Journal of Ophthalmic and Optometric Sciences. Volume 2, Number 3, Summer 2018. 11
This work is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
decreased left ventricular diastolic functions 
correlated with plasma B-type natriuretic 
peptide levels in PEX patients. Mitchell et 
al., 8 suggested that PEX might be associated 
with a history of angina or hypertension, acute 
myocardial infarction, or stroke. In another 
study designed to investigate the prevalence of 
glaucoma and CAD in patients with cataract 
and PEX, Andrikopoulos et al., 10 reported a 
positive association between PEX and the risk 
of CAD among subjects 50 years or older. 
Our study had some limitations including the 
small number of study subjects and the use 
of a low sensitivity test (treadmill exercise 
test) for detection of ischemic heart disease. 
Another limitation of the present study was 
that the information regarding the risk factors 
of ischemic heart disease was obtained from 
patient interviews and medical records, and 
was not checked by the authors. 
Using tests other than exercise test to increase 
the sensitivity of diagnosis and including a 
larger number of study participants might 
provide more information about the possible 
association between PEX and ischemic heart 
disease.
Conclusion
Based on our findings ocular PEX was not 
associated with increased risk of asymptomatic 








1. Lindberg JG. Clinical investigations on 
depigmentation of the pupillary border and 
translucency of the iris in cases of senile cataract and 
in normal eyes in elderly persons. Acta Ophthalmol 
Suppl. 1989;190:1-96.
2. Ritch R, Schlötzer-Schrehardt U, Konstas AG. Why 
is glaucoma associated with exfoliation syndrome? 
Prog Retin Eye Res. 2003;22(3):253-75.
3. Aasved H. Mass screening for fibrillopathia 
epitheliocapsularis, so-called senile exfoliation or 
pseudoexfoliation of the anterior lens capsule. Acta 
Ophthalmol (Copenh). 1971;49(2):334-43.
4. Schlötzer-Schrehardt U, von der Mark K, 
Sakai LY, Naumann GO. Increased extracellular 
deposition of fibrillin-containing fibrils in 
pseudoexfoliation syndrome. Invest Ophthalmol Vis 
Sci. 1997;38(5):970-84.
5. Schlötzer-Schrehardt U, Naumann GO. Ocular 
and systemic pseudoexfoliation syndrome. Am J 
Ophthalmol. 2006;141(5):921-37.
6. Schlötzer-Schrehardt UM, Koca MR, Naumann 
GO, Volkholz H. Pseudoexfoliation syndrome. 
Ocular manifestation of a systemic disorder? Arch 
Ophthalmol. 1992;110(12):1752-6.
7. Altintas O, Yuksel N, Sonmez GT, Ozkan B, 
Altintas L, Caliskan Ş, et al. Serum antiphospholipid 
antibody levels in pseudoexfoliation. J Glaucoma. 
2012;21(5):326-30.
8. Mitchell P, Wang JJ, Smith W. Association of 
pseudoexfoliation syndrome with increased vascular 
risk. Am J Ophthalmol. 1997;124(5):685-7.
9. Schumacher S, Schlötzer-Schrehardt U, Martus P, 
Lang W, Naumann GO. Pseudoexfoliation syndrome 
and aneurysms of the abdominal aorta. Lancet. 
2001;357(9253):359-60.
10. Andrikopoulos GK, Mela EK, Georgakopoulos 
CD, Papadopoulos GE, Damelou AN, Alexopoulos 
Cardiac disease in pseudoexfoliationNilforushan et al.
Journal of Ophthalmic and Optometric Sciences. Volume 2, Number 3, Summer 2018.
This work is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
12
DK, et al. Pseudoexfoliation syndrome prevalence 
in Greek patients with cataract and its association to 
glaucoma and coronary artery disease. Eye (Lond). 
2009;23(2):442-7.
11. Atalar PT, Atalar E, Kilic H, Abbasoglu OE, Ozer 
N, Aksöyek S, et al. Impaired systemic endothelial 
function in patients with pseudoexfoliation syndrome. 
Int Heart J. 2006;47(1):77-84.
12. Shrum KR, Hattenhauer MG, Hodge D. 
Cardiovascular and cerebrovascular mortality 
associated with ocular pseudoexfoliation. Am J 
Ophthalmol. 2000;129(1):83-6.
13. Ringvold A, Blika S, Sandvik L. Pseudo-
exfoliation and mortality. Acta Ophthalmol Scand. 
1997;75(3):255-6.
14. Brajkovic J, Kalauz-Surac I, Ercegovic A, Miletic-
Juric A, Susic N, Buric Z. Ocular pseudoexfoliation 
syndrome and internal systemic diseases. Acta Clin 
Croat. 2007;1:57-61.
15. Suratkal V, Shirke M, Lele RD. Treadmill ECG 
test combined with myocardial perfusion imaging for 
evaluation of coronary artery disease: analysis of 340 
cases. J Assoc Physicians India. 2003;51:561-4.
16. Gibbons RJ, Balady GJ, Bricker JT, Chaitman 
BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 
2002 guideline update for exercise testing: summary 
article. A report of the American College of 
Cardiology/American Heart Association Task Force 
on Practice Guidelines (Committee to Update the 
1997 Exercise Testing Guidelines). J Am Coll Cardiol. 
2002;40(8):1531-40.
17. Mégnien JL, Simon A. Exercise tolerance 
test for predicting coronary heart disease in 
asymptomatic individuals: A review. Atherosclerosis. 
2009;205(2):579-83.
18. McNeer JF, Margolis JR, Lee KL, Kisslo JA, Peter 
RH, Kong Y, et al. The role of the exercise test in 
the evaluation of patients for ischemic heart disease. 
Circulation. 1978;57(1):64-70.
19. Jonasson F. Solving the enigma of exfoliation 
glaucoma: a breakthrough in glaucoma research. 
Acta Ophthalmol Scand. 2007;85(8):808-9.
20. Streeten BW, Li ZY, Wallace RN, Eagle RC Jr, 
Keshgegian AA. Pseudoexfoliative fibrillopathy in 
visceral organs of a patient with pseudoexfoliation 
syndrome. Arch Ophthalmol. 1992;110(12):1757-62.
21. Streeten BW, Dark AJ, Wallace RN, Li ZY, 
Hoepner JA. Pseudoexfoliative fibrillopathy in the 
skin of patients with ocular pseudoexfoliation. Am J 
Ophthalmol. 1990;110(5):490-9.
22. Citirik M, Acaroglu G, Batman C, Yildiran 
L, Zilelioglu O. A possible link between the 
pseudoexfoliation syndrome and coronary artery 
disease. Eye (Lond). 2007;21(1):11-5. 
23. Sekeroglu MA, Bozkurt B, Irkec M, Ustunel 
S, Orhan M, Saracbasi O. Systemic associations 
and prevalence of exfoliation syndrome in patients 
scheduled for cataract surgery. Eur J Ophthalmol. 
2008;18(4):551-5.
24. Bojić L, Ermacora R, Polić S, Ivanisević M, Mandić 
Z, Rogosić V, et al. Pseudoexfoliation syndrome and 
asymptomatic myocardial dysfunction. Graefes Arch 
Clin Exp Ophthalmol. 2005;243(5):446-9.
25. Praveen MR, Shah SK, Vasavada AR,  Diwan RP, 
Shah SM, Zumkhawala BR, et al. Pseudoexfoliation 
as a risk factor for peripheral vascular disease: a case-
control study. Eye (Lond). 2011;25(2):174-9. 
26. Sainz Gómez C, Moreno-Montañés J, Escudero 
Berasategui JM, Sádaba Echarri LM, Fernández 
Hortelano A, García Layana A. Prevalence and 
risk factors of pseudoexfoliation syndrome in 
institutionalized geriatric patients in Navarra. Arch 
Soc Esp Oftalmol. 2003;78(7):383-8. (Article in 
Spanish)
27. Demir N, Ulus T, Yucel OE, Kumral ET, Singar 
E, Tanboga HI. Assessment of myocardial ischaemia 
using tissue Doppler imaging in pseudoexfoliation 
syndrome. Eye (Lond). 2011;25(9):1177-80.
28. Wang W, He M, Zhou M, Zhang X. Ocular 
pseudoexfoliation syndrome and vascular disease: 
a systematic review and meta-analysis. PLoS One. 
2014;9(3):e92767. 
29. Ciçek Yılmaz D, Yılmaz A, Göksel I, Cirit A, Sen 
F, Tamer L. Evaluation of left ventricular functions 
in patients with pseudoexfoliation syndrome using 
tissue Doppler echocardiography and its association 
Cardiac disease in pseudoexfoliation Nilforushan et al.
Journal of Ophthalmic and Optometric Sciences. Volume 2, Number 3, Summer 2018. 13
This work is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
with plasma BNP levels. Anadolu Kardiyol Derg. 
2014;14(5):422-6.
30. Emiroglu MY, Coskun E, Karapinar H, Capkın M, 
Kaya Z, Kaya H, et al. Is pseudoexfoliation syndrome 
associated with coronary artery disease? N Am J Med 
Sci. 2010;2(10):487-90.
31. French DD, Margo CE, Harman LE. Ocular 
pseudoexfoliation and cardiovascular disease: a 
national cross-section comparison study. N Am J 
Med Sci. 2012;4(10):468-73. 
Footnotes and Financial Disclosures
Conflict of interest:
The authors have no conflict of interest with 
the subject matter of the present study.
Cardiac disease in pseudoexfoliationNilforushan et al.
